Beating the Blues’ stands out as the most evidence-based ccbt programme available. The challenge Ultrasis has faced for the past two years has been how to engage with the changing NHS and provide a solution to their needs under the new commissioning arrangements and also how to ensure consistently high levels of completion of the programme by patients. The joint venture announced with CWP will help us to address these challenges by creating a range of products and services aligned to the needs of today's NHS that focus on the needs of both GP's and patients.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.